Also trades as: IN.TO (TSX) · $vol 0M
INM NASDAQ
InMed Pharmaceuticals Inc.
1W: -3.6%
1M: -1.5%
3M: -17.4%
YTD: +18.8%
1Y: -40.1%
3Y: -90.6%
5Y: -99.8%
$1.33
-0.02 (-1.48%)
Weekly Expected Move ±5.8%
$1
$1
$1
$1
$1
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Supply Chain
Cash Flow Trends
Operating Cash Flow
-$8.6B
-111185.8% ▼
Capital Expenditures
$3
+0.0% ▲
5Y CAGR: -71.9%
Free Cash Flow
-$8.6B
-111185.8% ▼
Dividends Paid
$432M
+0.0% ▲
Buybacks
$0
+0.0% ▲
Net Change in Cash
-$8.5B
-189898.4% ▼
Cash Flow Composition
Year-over-Year Growth
View Full Cash Flow Statement
| Line Item | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
| — Operating Activities — | |||||
| Net Income | -$19M | -$8M | -$8M | -$8M | -$12.6B |
| Depreciation & Amort. | $512K | $596K | $605K | $535K | $708M |
| Stock-Based Comp. | $698K | $278K | $138K | $119K | $107M |
| Change in Working Capital | -$3M | -$566K | -$369K | -$337K | -$76K |
| Other Non-Cash Items | $5M | $356K | $317K | $78K | $3.1B |
| Operating Cash Flow | -$16M | -$7M | -$7M | -$8M | -$8.6B |
| — Investing Activities — | |||||
| Capital Expenditures | -$39K | -$162K | -$9K | $0 | $0 |
| Acquisitions (Net) | -$209K | -$500K | $0 | $0 | $0 |
| Investment Purchases | $0 | -$42K | -$42K | -$42K | -$41M |
| Investment Sales | $0 | $42K | $42K | $42K | $41M |
| Other Investing | -$425K | $0 | $0 | $0 | $0 |
| Investing Cash Flow | -$673K | -$662K | -$9K | $0 | $0 |
| — Financing Activities — | |||||
| Net Debt Issuance | -$291K | $0 | $0 | $0 | $0 |
| Stock Repurchased | $0 | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 | -$432M |
| Other Financing | -$2M | $646 | -$562K | $4M | $526M |
| Financing Cash Flow | $15M | $11M | $5M | $12M | $94M |
| Net Change in Cash | -$1M | $3M | -$2M | $5M | -$8.5B |
| Cash End of Period | $6M | $9M | $7M | $11M | $2.2B |
| Free Cash Flow | -$16M | -$7M | -$7M | -$8M | -$8.6B |